DIABETES DIGEST

Keeping You in the Loop with Medtronic Diabetes.

Insulin Insights

New Research Findings: A Look Into ATTD 2021

InPen and Guardian Sensor

July 2021
The 14th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2021) took place last month with all sessions presented virtually. Registration is still being accepted to view recorded sessions until September 5, 2021 via https://attd.kenes.com/. This is a premier conference to showcase diabetes technology!

Read More

LOOKING AHEAD TO THE ADA SCIENTIFIC SESSIONS 2021: THE CRITICAL ROLE OF SHARED DECISION-MAKING IN DIABETES CARE

June 2021
With the addition of the InPenTM Smart* Insulin Pen system to the Medtronic portfolio, the team at Medtronic Diabetes has been thinking through how to best help people with diabetes (PWD)...Read More.

Training Tips

Bolusing Made as Easy as 1-2-3

Physician and Patient

July 2021
When it comes to managing patients on intensive insulin therapy, one size (method) certainly does not fit all. There are numerous factors that impact patient adherence to mealtime insulin coverage. Differences in patient preference, knowledge base, habits, and available resources mean that different patients may benefit from different bolus methods. While some patients may feel most comfortable with simplified bolus routines such as fixed doses or meal estimation...

Read More

SETTING UP THE INPENTM APP AND ACCESSING THE INSIGHTS AND CARELINKTM REPORTS

June 2021
The InPenTM Smart Insulin Pen is designed to help patients get started easily. Once the app has been downloaded, the Setup Wizard within the app guides users through the setup process. Patients have access to a User Guide and instructional videos within the app as well... Read More.

Portfolio Perspectives

The MiniMedTM 630G and 770G Insulin Pumps

Physician on Video Call

July 2021
Insulin pumps help patients optimize their diabetes management in various ways. Insulin pumps only use rapid-acting insulin. The action of rapid-acting insulin is more predictable and reproducible than long-acting insulin. The continuous infusion of basal—the small amounts of rapid-acting insulin—are more easily absorbed than long-acting insulin.1 Using an integrated continuous glucose monitor (CGM) allows automated features to be used.

Read More

GETTING TO KNOW THE INSIGHTS REPORT AND CARELINKTM REPORT

June 2021
The use of software-based diabetes data has been shown to improve diabetes outcomes. According to a 2017 systematic review of studies evaluating technology-enabled Diabetes Self-Management Education and Support, there were improvements in A1C ranging from 0.1% to 0.8% in 18 of the 25 studies....Read More.

Product Updates

MiniMedTM 770G System: Providing Connectivity for You and Your Patients

Child and caregiver.

Feb 2021
As of November 2020, Medtronic has been shipping the MiniMedTM 770G insulin pump system to patients throughout the US. This new system represents the latest in hybrid closed loop technology from Medtronic. It features automated insulin delivery* to help keep your patients in range and also includes Bluetooth® connectivity.

Thanks to the connectivity of the MiniMedTM 770G system, your patients can now easily share their data with you ahead of an upcoming appointment through automatic CareLinkTM data uploads. These automatic uploads can give you visibility to the information you need in order to make therapy adjustments for your patients.

Learn more about the new MiniMedTM 770G system and automatic CareLinkTM data uploads by visiting our product page.

*Refers to SmartGuardTM Auto Mode. Some user interaction required. Results may vary.

Product Portfolio Updates

Jan 2021
Medtronic is dedicated to driving innovation in diabetes management technologies so your patients can focus more on their lives and less on diabetes. Following two recent product launches, we have decided to streamline our product portfolio with two changes taking place in February 2021.
With the launch of the MiniMedTM 770G pump, we have decided to simplify our insulin pump offering and stop selling the MiniMedTM 670G pump after February 1, 2021...Read more.

 

Sample Meters Discontinuation

Dec 2020
We have an important announcement related to sample blood glucose meters for the MinMed™ 670G system, MiniMedTM 630G system, and MinimedTM 530G system. As of 11/01/2020, Medtronic will no longer be offering sample meters for CareLinkTM uploads from the pump. As patients transition to our MiniMedTM 770G system, this system is not approved for use with an Ascensia meter. The new MiniMedTM 770G system is approved for use with the Accu-Chek® Guide Link meter from Roche. This Roche meter does not include CarelinkTM system upload capability. Our MiniMedTM 770G system includes Bluetooth® connectivity to send data remotely to CareLinkTM system and for those without a compatible smartphone, we are offering a unique uploader that can be obtained from Medtronic at no cost. Samples of our new blood glucose meter will not be offered for our current and future systems.

We know you have utilized these sample meters in the past to assist your patients with CareLinkTM uploads. If you would like to request a blood glucose meter for the MinMedTM 670G system, MiniMedTM 630G system, or MinimedTM 530G system, you can do so by contacting Ascensia Diabetes Care directly at 862-225-2903 option 1.